Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-033547
Filing Date
2023-07-06
Accepted
2023-07-06 21:30:23
Documents
1
Period of Report
2023-07-03

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3080
  Complete submission text file 0001140361-23-033547.txt   4452
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZENTALIS PHARMACEUTICALS, INC. 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address
Epperly Melissa B, (Reporting) CIK: 0001807359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 231075071